Cargando…
CRISPR-Cas9-mediated loss of function of β-catenin attenuates intervertebral disc degeneration
Intervertebral disc degeneration is a very common medical condition causing pain and disability, and it cannot be reversed by available treatment options. Here we report that targeting β-catenin, a pivotal factor associated with disc degeneration, ameliorates disc degeneration in a mouse model of di...
Autores principales: | Fan, Yunshan, Zhao, Lan, Lai, Yumei, Lu, Ke, Huang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035381/ https://www.ncbi.nlm.nih.gov/pubmed/35505959 http://dx.doi.org/10.1016/j.omtn.2022.03.024 |
Ejemplares similares
-
The potential of CRISPR/Cas9 genome editing for the study and treatment of intervertebral disc pathologies
por: Krupkova, Olga, et al.
Publicado: (2018) -
IL‐6/YAP1/β‐catenin signaling is involved in intervertebral disc degeneration
por: Chen, Jian, et al.
Publicado: (2018) -
Degeneration of the intervertebral disc
por: Urban, Jill PG, et al.
Publicado: (2003) -
Pathomechanism of intervertebral disc degeneration
por: Oichi, Takeshi, et al.
Publicado: (2020) -
Treatment of Intervertebral Disc Degeneration
por: Xin, Jingguo, et al.
Publicado: (2022)